Register for free to listen to this article
Listen with Speechify
0:00
1:00
SANTA CLARA, Calif.—Agilent Technologies Inc. and FAPESP,the São Paulo Research Foundation, recently announced the selection of twojointly funded research projects. FAPESP, the principal funding agency foracademic research in the State of São Paulo, and Agilent are working togetherthrough the Partnership for Technological Innovation to further multinationalcollaboration and promote academic research in São Paulo, Brazil.
 
 
The two projects, approved following a joint call forsubmissions, will provide financial support to advance instrumentation andmeasurement techniques related to metabolomics in plant microbiology, massspectrometry and bioenergy. Launched in October 2011, the call for submissionsaims to identify, select and support world-class research projects to createknowledge and communicate results in the international scientific community.This will be done through close technical collaboration between leading facultymembers in the State of São Paulo and Agilent researchers.
 
 
One of the approved projects will involve the systematicstudy of the metabolites resulting from cellular processes under specificenvironmental and physiological conditions, specifically a study of thephysiological response of eucalyptus in the presence of high CO2 concentrationsand temperature variations.
 
 
The second study will identify volatile compounds producedby Brazilian cyanobacteria and explore their effects on other organisms in theecosystem.
 
 
"Agilent's partnership with FAPESP underscores ourcommitment to multinational research and to Brazil, a strategic growth area forus," said Mike McMullen, president of Agilent's Chemical Analysis Group, in astatement. "We look forward to our collaboration with leading researchers atthe University of São Paulo and State University of Campinas and the resultingadvances in fundamental understanding of important plants and microbesindigenous to Brazil."
 
 
Approved projects will run for up to 36 months. 
 

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue